Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Hubris therapy
Bristol-Myers suffers $21 bn self-inflicted wound
It's a marathon
Sprint to face challenges after SoftBank deal
Look on my work
Nokia phone demise a warning for all tech giants
Warren Appleseed
Apple falls far from Buffett's investing tree
Rosebud
Facebook better off liking title of top media firm
Know your strengths
Activist + private equity = no M&A for Symantec
Magical feast
Capital drought will spark 'Unicorn' M&A orgy
Location, location, location
Even Facebook can't make distance disappear
Pfizzling benefits
Pfizer's $150 bn plan is high-risk, low-benefit
Walk the walk
Twitter CEO's creative giveback is promising start
Gracefully maturing
Google and Amazon grapple happily with maturity
Join the club
Elon Musk whistles past Tesla's graveyard
One wing and a prayer
New Twitter CEO flaps with one wing behind back
Xi whiz
Xi Jinping parades Silicon Valley's tech hostages
Donor card
Asset-stripping Yahoo could mean profitable relief
Fantasy valley
Tech's real China syndrome victims are yet to fall
Don't drink and pink
'Female Viagra' maker seems to have convinced FDA by dint of a PR drive
Short-term pain
Wal-Mart's 'investment' in wages may pay off
For the birds
Twitter's mealy-mouthed strategy is hard to follow
Time out
Apple has time on its side
 "Robert Cyran")
